Screening mammography for early diagnosis of breast cancer: Facts, controversies, and the implementation in Israel

Harefuah

Volumn 142, Issue 4, 2003, Pages

  Allweis, Tanir M ^a   Nissan, Aviram ^a   Spira, Ram M ^a   Sklair Levy, Miri ^a   Freund, Herbert R ^a   Peretz, Tamar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Early diagnosis; Israel; Mortality; Screening mammography

Indexed keywords

ADULT; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MAMMOGRAPHY; META ANALYSIS; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; ISRAEL; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS;

EID: 0038637775     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Loprinzi CL & Thom SL, Understanding the utility of adjuvant systemic therapy. J Clin Oncol, 2001; 19: 972-979.
2. Mushlin AI, Kouides RW & Shapiro DE, Estimating the accuracy of screening mammography: a meta-analysis. Am J Prev Med, 1998; 14: 143-153.
3. Kavanagh AM, Giles GG, Mitchell H & al, The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J Med Screen, 2000; 7: 105-110.
4. Shapiro S, Venet W, Strax P & al, Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst, 1982; 69: 349-355.
5. Shapiro S, Strax P & Venet L, Periodic breast cancer screening in reducing mortality from breast cancer. JAMA, 1971; 215: 1777.
6. Tabar L, Fagerberg G, Duffy SW & al, The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Commun Health, 1989; 43: 107-114.
7. Tabar L, Fagerberg G, Chen HH & al, Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer, 1995; 75: 2507-2517.
8. Andersson I, Aspegren K, Janzon L & al, Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ, 1988; 297: 943-948.
9. Andersson I & Janzon L, Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr, 1997;63-67.
10. Frisell J, Eklund G, Hellstrom L & al, Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat, 1991; 18: 49-56. Bjurstam N, Bjorneld L, Duffy SW & al, The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. J Natl Cancer Inst Monogr, 1997; 22: 53-55.
11. Frisell J, Eklund G, Hellstrom L & al, Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat, 1991; 18: 49-56. Bjurstam N, Bjorneld L, Duffy SW & al, The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. J Natl Cancer Inst Monogr, 1997; 22: 53-55.
12. Bjurstam N, Bjorneld L, Duffy SW & al, The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer, 1997; 80: 2091-2099. Comment in: Cancer, 1997; 80: 2035-2039; Cancer, 1998; 83: 186-190.
13. Bjurstam N, Bjorneld L, Duffy SW & al, The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer, 1997; 80: 2091-2099. Comment in: Cancer, 1997; 80: 2035-2039; Cancer, 1998; 83: 186-190.
14. Bjurstam N, Bjorneld L, Duffy SW & al, The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer, 1997; 80: 2091-2099. Comment in: Cancer, 1997; 80: 2035-2039; Cancer, 1998; 83: 186-190.
15. Alexander FE, Anderson TJ, Brown HK & al, The Edinburgh randomized trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer, 1994; 70: 542-548.
16. Alexander FE, Anderson TJ, Brown HK & al, 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet, 1999; 353: 1903-1908.
17. Miller AB, Baines CJ, To T & al, Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ, 1992; 147: 1459-1476.
18. Miller AB, To T, Baines CJ & al, The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr, 1997; 22: 37-41.
19. Baines CJ, Miller AB, Kopans DB & al, Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol, 1990; 155: 743-747.
20. Kopans DB & Feig SA, The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol, 1993; 161: 755-760.
21. Burhenne LJ & Burhenne HJ, The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol, 1993; 161: 761-763.
22. Tarone RE, The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer, 1995; 75: 997-1003.
23. Miller AB, To T, Baines CJ & al, Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst, 2000; 92: 1490-1499.
24. Gotzsche PC & Olsen O, Is screening for breast cancer with mammography justifiable? Lancet, 2000; 355: 129-134.
25. Kopans DB, Halpern E & Hulka CA, Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer, 1994; 74: 1196-1203.
26. rd & al, Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr, 1997; 22:87-92.
27. NIH Consensus Statement. Breast cancer screening for women ages 40-49: NIH Consens Statement, 1997; 21-23: 1-35.
28. National Cancer Institute, Statement from the National Cancer Institute on the National Cancer Advisory Board recommendations on mammography. Bethesda, MD: National Cancer Institute, 1997.
29. Leitch AM, Dodd GD, Costanza M & al, American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin, 1997; 47: 150.
30. Shapiro S, Coleman EA, Broeders M & al, Breast cancer screening programs in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol. 1998; 27: 735-742.
31. Elmore JG, Barton MB, Moceri VM & al, Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med, 1998; 338: 1089-1096.
32. Rankin SC, MRI of the breast. Br J Radiol, 2000; 73: 806-818.